Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Eurogin
 

May 30 - June 1, 2021

Congress Center • Düsseldorf, Germany

  • 
  • Scientific Information
    • Message from the Chairman of the Scientific Committee
    • Program Committee
    • Program Objectives
    • Key Features And Target Audience
    • Previous Congress Presidents
    • Previous Congresses
  • Program & CME
    • Program Overview
    • Program Topics
    • HPV And Head & Neck Forum
  • Registration
    • Online Registration
    • Registration Information
  • Abstracts & Posters
    • Abstract Information
    • Abstract Submission
    • Abstract Topics
  • Sponsorship And Exhibition
    • Sponsorship Information
    • Sponsor Brochure 2021
    • Sponsors and Exhibitors
    • Ethical Compliance
    • Exhibition Floorplan
  • Congress Information
    • Congress Venue
    • Contact us
    • newsletter
    • Legal Information
    • Picture Gallery 2019
  • Home
  • Program & CME
  • HPV And Head & Neck Forum

HPV HEAD & NECK FORUM

Sunday, May 30, 2021

Coordinators: E. Rettig (USA), P. Klussmann (Germany)

The EUROGIN HPV and Head & Neck Cancer Forum highlights areas of active investigation in the field of HPV and head and neck cancers. This year's forum will offer an extended review of screening for early cancer detection that will occupy two sessions, molecular characterization and potential biomarkers for prognosis and monitoring of HPV related oropharyngeal cancer patients, new insights on emerging treatment strategies and the role of HPV in benign disease such as recurrent respiratory papillomatosis

A dedicated debate session will focus on the controversies regarding the impact of HPV infection on oro-pharyngeal cancer, including diagnosis, management and decision making.

Overview of Sessions
Subject to change

Epidemiology & Screening
Chair: T. Waterboer (Germany), U. Wieland (Germany)
  • HPV vaccination and HPV-OPC prevention • M. Brogli Däppen (Germany)
  • Biomarkers for HPV-OPC • E.-S. Prigge (Germany)
  • Familial occurence of OPSCC and other HPV-associated cancers • K. Hemminki (Germany)
  • Screening for HPV-OPC: Overview of screening concepts • H. Robbins (France)
  • Risk-stratified screening of OPSCC - Proof of concept trial • M. Lehtinen (Sweden)
  • Cost-effectiveness of OPSCC elimination • S. Vänskä (Sweden)
Management & Surveillance
Chair: P. Bossi (Italy), A. Psyrri (Greece)
  • Work up of unknown primary • A. Arora (UK)
  • Updates in deintensification • C. J. Busch (Germany)
  • Impact of deintensification on HRQOL outcomes • C. Simon (France)
  • High-risk & recurrent disease • H. Mehanna (UK)
  • Surgical deintensification • T. Jones (UK)
Molecular & Immunologic considerations
Chair: E.-J. Speel (Netherlands), J. Klozar (Czech Republic)
  • HPV viral integration • S. Virani (France)
  • Molecular modifiers of prognosis in HPV-OPC • L. Licitra (Italy)
  • Role of biomarkers in HPV-OPC treatment • N. Wuerdeman (Germany)
  • Immune microenvironment in HPV-OPC • T. Dalianis (Sweden)
  • HPV-specific T cell response • S. Van der Burg (Netherlands)
Submitted abstracts
Chair: J. P. Klussmann (Germany), H. Mehanna (UK)

ABOUT EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

ETHICAL COMPLIANCE

TRUSTED PARTNER


USEFUL LINKS

  • EUROGIN PORTAL |
  • Previous events |
  • Legal Information |
  • Cancellation Policy |
  • Delegates Terms & Conditions |
  • Refund Request Process

ENDORSED BY / PARTNERSHIPS

Informa Markets

Copyright © 2020. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions